Table 3.

Univariate Analyses of Predictors of Graft Survival After Stratification by Center

	HR (95% CI)	P
Donor
Age, decade	1.13 (1.10–1.15)	<.01
Female	1.12 (1.04–1.22)	<.01
Height, 10 cm	0.91 (0.88–0.94)	<.01
Weight, 5 kg	0.99 (0.98–1.00)	.06
Cause of death (reference, head trauma)
Anoxia	1.18 (1.04–1.34)	.01
Cerebrovascular accident	1.39 (1.28–1.52)	<.01
Other	1.06 (0.83–1.36)	.64
Height difference (recipient–donor)	1.05 (1.02–1.08)	<.01
HBcAb (+) donor/HBV (−) recipient	1.17 (1.00–1.38)	.05
Recipient
Age, decade	1.09 (1.05–1.14)	<.01
Female	1.02 (0.93–1.10)	.70
MELD at transplantation, 5 points	1.06 (1.03–1.08)	<.01
Indication for transplantation, HCV	1.26 (1.17–1.36)	<.01
Ln creatinine	1.25 (1.16–1.34)	<.01
Insurance (reference, private)
Medicaid	1.10 (0.98–1.23)	.11
Public	1.23 (1.12–1.35)	<.01
Other	0.88 (0.56–1.39)	.59
Transplant
Donation after cardiac death	1.51 (1.27–1.80)	<.01
Partial/split liver	1.06 (0.80–1.42)	.67
Cold ischemia time	1.01 (1.00–1.02)	.09
Regional share	1.15 (1.04–1.28)	<.01
National share	1.11 (0.94–1.31)	.21
ABO incompatibility	1.44 (0.81–2.56)	.22

HBcAb, hepatitis B core antibody positive; HBV, hepatitis B virus; Ln, natural log.